Magnesium Sulphate for Preterm Birth (MASP Study) (MASP)
Administration of Antenatal Magnesium Sulphate for Prevention of Cerebral Palsy and Death in Preterm Infants (MASP-STUDY)
Sponsor: Hvidovre University Hospital
This PHASE3 trial investigates Cerebral Palsy and is currently completed. Hvidovre University Hospital leads this study, which shows 10 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Mar 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE3
▶ Show 5 earlier versions
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE3
-
Sep 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE3
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hvidovre University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalborg, Denmark , Aarhus, Denmark , Copenhagen, Denmark , Esbjerg, Denmark , Herlev, Denmark , Hillerød, Denmark , Holbæk, Denmark , Hvidovre, Denmark , Kolding, Denmark , Næstved, Denmark and 4 more locations